Pallarés Giner, RomanLiñares Louzao, JosefinaGudiol i Munté, Francesc2020-04-242020-04-241996-01-040028-4793https://hdl.handle.net/2445/157301To the Editor: since the first description of infection caused by β-lactam-resistant Streptococcus pneumoniae, the optimal empirical antibiotic therapy for patients with suspected meningitis caused by this microorganism has remained unknown. Hofmann et al. (Aug. 24 issue)1 reported a 25 percent prevalence of penicillin-resistant S. pneumoniae isolates and a 9 percent prevalence of cephalosporin-resistant isolates among 431 patients with invasive pneumococcal infections in Atlanta. The authors recommended adding vancomycin to the initial therapeutic regimen of patients with suspected pneumococcal meningitis.3 p.application/pdfeng(c) Massachusetts Medical Society, 1996Resistència als medicamentsPneumococsMortalitatDrug resistanceStreptococcus pneumoniaMortalityinfo:eu-repo/semantics/article1242642020-04-24info:eu-repo/semantics/openAccess